David Marshall Email

VP Finance and Optimization . Pfanstiehl

Current Roles

Employees:
121
Revenue:
$24.3M
About
Founded in 1919 by Carl A. Pfanstiehl, our company specializes in isolation, purification, custom synthesis and scale-up development of cGMP, high purity and low endotoxin (HPLE) Injectable Formulation Components, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (APIs), in gram to multi-ton commercial quantities. Tried and true parenteral excipients include trehalose, sucrose, mannitol, maltose, sorbitol, and hydroxypropyl betacyclodextrin. Upstream, high purity media components include animal component free galactose, mannose, and L-arginine. At Pfanstiehl we pride ourselves on being customer focused and are amenable to producing cGMP components on a custom basis to solve formulation challenges for our clients.
Pfanstiehl Address
1219 Glen Rock Ave
Waukegan, IL
United States
Pfanstiehl Email

Past Companies

Pfanstiehl, Inc.Vice President of Finance and Optimization
Applied Accoustics InternationalChief Financial Officer
UGN, Inc.Plant Controller

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.